Accessibility Menu
BioLife Solutions Stock Quote

BioLife Solutions (NASDAQ: BLFS)

$27.69
(-0.6%)
-0.17
Price as of October 21, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$27.69
Daily Change
(-0.6%) $0.17
Day's Range
$27.69 - $28.56
Previous Close
$27.69
Open
$27.97
Beta
1.79
Volume
10,066
Average Volume
457,422
Market Cap
1.3B
Market Cap / Employee
$27.68M
52wk Range
$19.1 - $29.55
Revenue
-
Gross Margin
0.58%
Dividend Yield
N/A
EPS
-$0.12
CAPs Rating
-
Industry
Life Sciences Tools and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

BioLife Solutions Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BLFS+20.3%-3.15%-0.64%-95%
S&P+15.06%+95.03%+14.29%+1,533%

BioLife Solutions Company Info

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$25.42M-10.3%
Gross Profit$15.73M12.5%
Gross Margin61.86%12.5%
Market Cap$1.02B3.8%
Market Cap / Employee$6.44M0.0%
Employees159-61.6%
Net Income-$15.84M-121.6%
EBITDA-$15.26M-3863.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$31.90M44.7%
Accounts Receivable$10.06M-44.3%
Inventory27.7-14.8%

Liabilities

Q2 2025YOY Change
Long Term Debt$11.60M-48.5%
Short Term Debt$12.22M-9.1%

Ratios

Q2 2025YOY Change
Return On Assets-5.25%9.6%
Return On Invested Capital-8.68%2.7%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$5.63M2.9%
Operating Free Cash Flow$7.37M14.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book3.563.693.072.90-1.10%
Price to Sales9.3711.0010.2010.0328.31%
Price to Tangible Book Value14.0614.588.437.79-29.64%
Price to Free Cash Flow TTM204.61239.6192.9187.64-
Enterprise Value to EBITDA1531.83-1304.256114.01-63.67-97.52%
Free Cash Flow Yield0.5%0.4%1.1%1.1%-
Return on Equity-9.9%-6.1%-3.3%-6.0%-66.36%
Total Debt$39.27M$30.17M$26.95M$23.82M-33.77%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.